chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from nurse practitioner (N. P.) refers to a female patient of unknown age. On 04-SEP-2013 the patient was vaccinated with a dose of PNEUMOVAX23 (Lot#, dose and route not reported). Concomitant therapy was not reported. On an unknown date the patient experienced a local reaction, two inches in diameter and erythremia around the PNEUMOVAX23 injection site. N. P. reported that there was no drainage at injection site. The patient received the vaccine at an unspecified healthcare provider's office. The patient did not sought medical attention and no treatment was given for the adverse event. The patient's outcome was unknown. Additional information has been requested.
Shingles.  My doctor prescribed Prednisone and Valacyclovir.
Sinus infection; very bad cough; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection) and COUGH (very bad cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SINUSITIS (Sinus infection) and COUGH (very bad cough). At the time of the report, SINUSITIS (Sinus infection) and COUGH (very bad cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included unspecified antibiotics and unspecified steroids. No concomitant medications were provided by reporter.   Reporter did not allow further contact
Admission to the CICU with chest pain found to have ST elevation on EKG with concerns for myocarditis and pericarditis. Chest pain resolved with Toradol and morphine. Troponin elevated to 50 on admission and is being trended.
a six month old male patient received only the Pentacel liquid Dtap IPVcomponent without mixing the powder HIB/No AE; Initial information and additional information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 6 months old male patient who only the pentacel liquid dtap ipv component without mixing the powder hib while receiving vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] lot U6397AA, expiry date: 29-Sep-2020, dose: 0.5 ml via intramuscular route in the left thigh on 18-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVENAR) and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE).  It was an actual medication error due to inappropriate reconstitution technique.  Symptoms: None reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Constant ringing in the ears. Have an appointment to see an Otolaryngologist on Friday, October, 16, 2015.
Pt walked (20 feet) to restroom with mother, told mother she did not feel well, lost tone, fell, became incontinent of urine.  No tonic, clonic movements or abnormal posturing. Attended immediately, easily arousable and oriented, yet very drowsy. No other injuries noted. Vital signs wnl. Patient transported to ED by 1:22 PM.
Significant body aches; Chills; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to peanut. Concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown, if the patient received any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced significant body aches, chills and brain fog. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events significant body aches, chills and brain fog was resolved on an unknown date.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient was at clinic to receive his primary/monovalent Covid vaccine. Patient was mistakenly given a Bivalent Pfizer dose instead of his primary dose.
Initial report received from healthcare professional on 24 October 2014. A 58-year-old female patient, whose medical history and concomitant medications were not reported, had received an intramuscular dose of FLUZONE QIV (Batch number UI173AA, expiry date 30 June 2015, and dose number was not reported) in to the left deltoid on 02 October 2014. The patient had experienced sore arm when lifts arm to a 90 degree angle and soreness at the injection site on an unspecified date after vaccination. Lab investigation and corrective treatment were not reported. The patient had no illness at the time of vaccination, pre-existing diagnosed allergies and birth defects were reported as unknown. The outcome of the event was unknown at the time of this report. List of documents held by sender: none. Follow up unsolicited report received from a health care professional on 15 January 2015. It was reported that the patient had received 0.5 ml dose of FLUZONE QIV.
Information has been received from a nurse referring to a patient of unknown age and gender. Information about concurrent condition and medical history was not provided. On 21-AUG-2018 the patient received Oka-Merck PROQUAD (lot # R008203, expiration date 16-SEP-2019; indication for prophylaxis; dose was not reported) and MERCK STERILE DILUENT (strength, dose, frequency, route, lot number, expiration date and indication were not provided) via intradermal route (incorrect route of drug administration). No adverse effects reported.
A non-serious spontaneous report of shaking, nasal passage irritation, sweating, chills, headache, and nausea has been received from a consumer concerning a patient of unknown age subsequent to FLUMIST.  The patient's past medical history includes mild anemia.  The patient received FLUMIST on 22-Aug-2008 at 0920.  The patient experienced shaking, chills, sweating (enough to create six inch by three inch large pit stain under her arms), headache (that lasted all day), nasal passage irritation, and intermittent nausea on the same day that FLUMIST was received.  The outcome was not reported.
Horrible daily headaches starting 6 days after vaccine on 1/5/22, still having them as of 2/21/22. Seeing neurologist but so far no diagnosis or treatments are helping. CT scan showed up ruptured brain aneurysms, but unknown if they are causing the headaches
Patient reports that within a couple hours of her PCV13 injection she became dizzy, weak, fatigued and she developed a fever. She also reports injection site was red. She states that she felt weak and fatigued for a week after injection.
Hypertension. Muscle weakness and fatigue. Short of breath. Loss of sensation in lower legs. Tingling and numbness on left side
Patient stated that he hurt all over his body the next day, and that he had blisters on his feet.
Pain returned and felt like someone was jabbing the arm with a knife; Pain spread to clavicle area; Unbearable arm pain; Severe pain in right arm/ arm felt heavy and painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Severe pain in right arm/ arm felt heavy and painful), PAIN IN EXTREMITY (Pain returned and felt like someone was jabbing the arm with a knife), PAIN (Unbearable arm pain) and PAIN (Pain spread to clavicle area) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cancer (Cancer survivor).    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Severe pain in right arm/ arm felt heavy and painful). On 20-Feb-2021, the patient experienced PAIN (Unbearable arm pain). On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain returned and felt like someone was jabbing the arm with a knife) and PAIN (Pain spread to clavicle area). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) for Pain, at a dose of 400 mg. On 23-Feb-2021, PAIN IN EXTREMITY (Severe pain in right arm/ arm felt heavy and painful) and PAIN (Unbearable arm pain) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain returned and felt like someone was jabbing the arm with a knife) and PAIN (Pain spread to clavicle area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Patient is here today for COVID-19 immunization per federal guidelines/written order. See immunization activity for details. Patient was observed post-immunization for a minimum of 15 minutes with evidence of dizziness.  Anaphylaxis Management Standing Order protocol initiated.  Physician/APP notified of patient condition.   Additional orders received: none.  COVID-19 (MRNA) VACCINE Allergen added to patient's Allergies. VAERS reporting completed as appropriate. Standing order not needed, after 15 minute waiting time patient reported feeling lightheaded. Assisted to table and to lying down. She reports she has notified her Mother of this incident. VS 1440 BP 122/69, P 82, pulse ox 97%, alert. Oriented, skin warm and dry, pink. Patient states this has happened to her before with blood draws. Observed, 1455 BP 122/74, p 88, ox 98%. Assisted to sitting then standing BP 107/77, P 88, Ox 97%. Remains alert. After 30 minutes total observation patient was discharged in stable condition, feeling improved.
Shingrex vaccine. Pain redness swelling at site getting progressive through day 4. Bumps pain swelling noticed several inches from injection site as well. Continuing through day 5. Fatigue noticed day 2,3.
This spontaneous report as received from a registered nurse refers to a unspecified number of female patients over the age of 26 years. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with GARDASIL (dose, route, lot number and expiration date were not reported). No co-suspect and concomitant therapies were reported. No adverse effects reported. Additional information is not expected. No allowed to contact physician.
9-4-07 Follow up on pneumonia, lungs clear 9-5-07 Woke up during night vomiting and low grade temp. Started Zofran Vomiting that morning and wouldn't eat
This spontaneous report was received from a Licensed Practical Nurse referring to a patient of unknown gender who would be 4 years old. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with an improperly stored dose of PROQUAD lot # M003435 and expiration date on 19-JUL-2017, lot # M038229 and expiration date on 06-MAR-2018 or lot M044020 with expiration date on 01-MAY-2018 (dose and route of administration were not reported) for prophylaxis. The reporter could not provide details of which lot number the patient received. The doses of PROQUAD were exposed to a temperature excursion of 14.9 degrees Fahrenheit (°F) during a time frame of 11 hours, which was detected by the data logger. There was no prior temperature excursion and no adverse events were reported. This is one of the several reports received from the same source.; Sender's Comments:  US-009507513-1710USA008686: Linked Report: US-009507513-1710USA008688: US-009507513-1710USA008690: US-009507513-1710USA008691: US-009507513-1710USA008692: US-009507513-1710USA008693: US-009507513-1710USA008685: US-009507513-1710USA008684:  US-009507513-1710USA008689:
pt recvd vax & 4 hrs p/vax exp dyspnea, SOB, panic attack, pain, stabbing feeling in the back, elevated BP, itching, red blotchy skin, difficulty swallowing & face swelling;
This spontaneous report received from a patient via social media (J&J) via a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced seizure disorder, and coma for two months. The reporter stated that, "PRIVATE" put me in a coma for 2 months and now I have a seizure disorder thanks to them". The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from coma for two months, and the outcome of seizure disorder was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20220552900 -COVID-19 VACCINE AD26.COV2.S- coma for two months, seizure disorder. The event(s) has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
This spontaneous report as received from a consumer refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with ZOSTAVAX, subcutaneous injection (exact dose, lot # and expiration date were not reported), for prophylaxis. On an unknown date, three days after vaccination, the patient experienced injection site erythema, injection site pruritus and injection site warmth. The outcome of injection site erythema, injection site pruritus and injection site warmth was no reported. The causality assessment between the events and ZOSTAVAX was not provided.
has not felt this good in years; nose bleed when sneezed and coughed; feet were red; awake hallucinations; shaking chills,teeth were chattering; myalgia; arthralgia; sever nausea; violent vomiting; headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HALLUCINATION (awake hallucinations) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 031A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021. Concurrent medical conditions included Pituitary apoplexy, Myelosuppression since January 2021, Thrombocytopenia since January 2021 and Leukopenia since January 2021. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LIOTHYRONINE and CORTISONE for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced HALLUCINATION (awake hallucinations) (seriousness criterion medically significant), ERYTHEMA (feet were red), CHILLS (shaking chills,teeth were chattering), MYALGIA (myalgia), ARTHRALGIA (arthralgia), NAUSEA (sever nausea), VOMITING (violent vomiting) and HEADACHE (headache). On 20-Mar-2021, the patient experienced EPISTAXIS (nose bleed when sneezed and coughed). On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (has not felt this good in years). On 20-Mar-2021, HALLUCINATION (awake hallucinations), ERYTHEMA (feet were red), CHILLS (shaking chills,teeth were chattering), MYALGIA (myalgia), ARTHRALGIA (arthralgia) and HEADACHE (headache) had resolved, NAUSEA (sever nausea) and VOMITING (violent vomiting) outcome was unknown. At the time of the report, EPISTAXIS (nose bleed when sneezed and coughed) and THERAPEUTIC RESPONSE UNEXPECTED (has not felt this good in years) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitants medications also included Fludroscortisone, Cabergoline, Pantoprazole, Aspirin 81mg, Testosterone Gel and Vitamin E.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This report also refers to a case of positive therapeutic effect.   This case was linked; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This report also refers to a case of positive therapeutic effect.
Got symptoms of a common cold. Sneezing and a very runny nose plus a slight cough. I still have the cold on 10/21/2010 but it is moderating.
experiencing a stroke in both eyes that affected her whole left side of the bodyand moved to the right side; lost of sight after taking moderna vaccine; huge lump on arms; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Apr-2021 and was forwarded to Moderna on 21-Apr-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CEREBROVASCULAR ACCIDENT (experiencing a stroke in both eyes that affected her whole left side of the bodyand moved to the right side), BLINDNESS (lost of sight after taking moderna vaccine) and LIMB MASS (huge lump on arms) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CEREBROVASCULAR ACCIDENT (experiencing a stroke in both eyes that affected her whole left side of the bodyand moved to the right side) (seriousness criterion hospitalization), BLINDNESS (lost of sight after taking moderna vaccine) (seriousness criterion hospitalization) and LIMB MASS (huge lump on arms) (seriousness criterion hospitalization). The patient was hospitalized for 3 days due to BLINDNESS, CEREBROVASCULAR ACCIDENT and LIMB MASS. At the time of the report, CEREBROVASCULAR ACCIDENT (experiencing a stroke in both eyes that affected her whole left side of the bodyand moved to the right side), BLINDNESS (lost of sight after taking moderna vaccine) and LIMB MASS (huge lump on arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments  No concomitant medications were reported.  No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Very limited information regarding these events has been provided at this time. Further information has been requested.
patient went back to the procedure center after receiving vaccine after 15 min observation and complained of N, abdominal pain and out of body experience with inability to talk or describe what happened. Palpitations. No CP, SOB, wheezing or visual changes. HR 140's w occ PVCs, SBP 160-170's SpO2 100% with pt appearing flushed and drowsy. O2 NC, NS 1 liter IV, zofran 4mg IVP x1 given. Admitted to procedure center at 1500 and discharged at 2359.
Child came to clinic with school request for MMR-DTaP-IPV and PCV. I administered the shots, parent gave me the vaccine card and then noticed it had all been stamped the day before. She said she showed the school the card today and gave her The request for the shots listed above-so she thought it had to be done. The Dr. called Poison Control. It appears to be alright. I called VAERS who suggested I report it.
treatment of COVID-19; treatment of COVID-19; This is a spontaneous report received from a contactable reporter (consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Feb2021 as dose 1, single (batch/lot number: EL3248), in right arm, on 09Mar2021 as dose 2, single (batch/lot number: EN6206), in right arm and on 19Oct2021 as dose 3 (booster), single (batch/lot number: FF2593) at the age of 68 years, in right arm for COVID-19 immunization. The patient's relevant medical history included: "COPD" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "treatment of COVID-19". The patient underwent the following laboratory tests and procedures: COVID 19 test: positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid from 19Oct2022 to 23Oct2022.
Patient stated that she had the vaccine on 9/2/2015 and went to the hospital on 9/7/2015 due to pain and severe swelling at site of Prevnar 13 injection site.  She is still having pain at injection site as of 9/21/2015.
Pt vaccinated w/MMR developed bilateral orchitis one mo folowing MMR vaccination. Temp 101 L testicle 1XN size tender. Also tender epididymison on lt. Seen by Dr 29AUG90 treated w/Motrin & bactrim DS; F-UP 6SEP90 complete resolution.
approximately 4 hours after receiving the vaccine, patient had fatigue, chills, and body aches. Patient had a fever.
Patient presented to ED 3 days post-vaccination with cc of anxiety, headache and hallucinations attributed to vaccine
I developed cellulitis because the shot was given too low on my arm. I have to take an antibiotic. My arm is swollen, red and itchy.